DR. JOSHUA BOGER

Dr. Boger founded Vertex in 1989 and was the company’s Chief Executive Officer from 1992 until May 2009. He served in the additional role of Chairman of the Board from 1997 until 2006. After retiring as CEO in May 2009, he continued on the Vertex Board of Directors until June 2017 and was Chair of its Science and Technology Committee. In early June 2023, Dr. Boger was named Executive Chairman of Alkeus Pharmaceuticals.

Dr. Boger began his industry career at Merck in 1978. Immediately before he founded Vertex, he was Senior Director of Basic Chemistry at Merck Sharp & Dohme Research Laboratories and headed both the Departments of Chemistry of Immunology & Inflammation and of Biophysical Chemistry. Dr. Boger holds a B.A. in chemistry and philosophy from Wesleyan University and A.M. and Ph.D. degrees in chemistry from Harvard University.